Table 3.
Study | Number of patients | Intervention | Duration | Outcome |
---|---|---|---|---|
Hermida et al 200536 | 200 | Valsartan 160 mg morning or evening | 3 months | Protein excretion reduced by 41% in those receiving night dose |
Hermida et al 200539 | 148 | nondippers Valsartan 160 mg morning or evening | 3 months | 75% of those receiving night dose became dippers with reduction of proteinuria |
Hoshino et al38 | 31 | Amlodipine-Olmesartan combination – morning or evening | 8 weeks | Urinary albumin/creatinine ratio was 42.5 ± 59.9 mg/g versus 75.3 ± 26.4 mg/g in bedtime versus daytime administration |